Google Chrome
Safari
Firefox
Edge
Article / Jun 01, 2020
Outsourcing Formulation Development & Manufacturing: Specialized Capabilities for Small & Large Molecules
Drug Development & Delivery, June 2020
Search
Procurement
We partner, connect and align to shape supplier solutions that help Hovione reach its growth and objectives.
Press Release / Sep 23, 2020
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Press Clipping / Sep 23, 2020
Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million
Business Wire, September 23, 2020
Press Clipping / Sep 23, 2020
Hovione to support production of antiviral Veklury for COVID-19
Manufacturing Chemist, September 23, 2020
Press Clipping / Sep 23, 2020
Hovione Announces Partnership to Produce Ligand’s Captisol; Used in Gilead’s Covid-19 Treatment
Drug Development & Delivery, September 23, 2020
Hovione at a glance
Get to know more about our history
Explore what we do
Hovione is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.
Our experts content
We invite you to read, listen and learn with our experts content.